Skip to content

Julie A. Marusich

14 papers in the library · 229 citations · publishing 2012-2026

Papers

Sort Most recent Most cited

The influence of acute cannabis smoking on cigarette and e-cigarette puff topography and subjective effects in people who use cannabis, cigarettes, and e-cigarettes.

Experimental and Clinical Psychopharmacology October 22, 2026 C Austin Zamarripa, Tory R Spindle, Dustin C Lee et al.

Co-use of smoked/vaped tobacco and cannabis is increasing with expanding legalization, yet controlled clinical studies examining mechanisms underlying co-use remain limited. This study evaluated whether acute smoked cannabis influences subsequent use ("chasing") of combustible cigarettes and e-cigarettes among people who use cannabis, cigarettes, and e-cigarettes. Twenty adults who used...

Cannabimimetic and discriminative stimulus effects of hexahydrocannabinols in mice.

Journal of Psychopharmacology July 1, 2025 Julie A. Marusich, Cassandra Prioleau, Luli R Akinfiresoye 1 citation

Hexahydrocannabinol (HHC) recently appeared on the recreational drug market and is often sold as a legal replacement for Δ9-tetrahydrocannabinol (Δ9-THC). Users primarily consume HHC for recreational purposes, but adverse effects have been reported. Given the scant literature on HHC, additional research is needed to better understand its effects. The present study sought to determine whether...

DOI: 10.1177/02698811251330739 (opens in new tab) Full text (opens in new tab) Hhc Cannabinoid tetrad Delta-9-THC Drug discrimination +1

Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.

Progress in Neuro-Psychopharmacology and Biological Psychiatry June 8, 2024 Jenny L Wiley, Julie A. Marusich, Bruce E. Blough et al.

The cannabis plant contains several cannabinoids, and many terpenoids that give cannabis its distinctive flavoring and aroma. Δ9-Tetrahydrocannabinol (Δ9-THC) is the plant's primary psychoactive constituent. Given the abuse liability of Δ9-THC, assessment of the psychoactive effects of minor cannabinoids and other plant constituents is important, especially for compounds that may be used...

Experimenter administered Δ9-THC decreases nicotine self-administration in a rat model.

Pharmacology, Biochemistry, and Behavior October 2023 Antony D Abraham, Jenny L Wiley, Julie A. Marusich

The co-use of nicotine and cannabis has been steadily rising in the United States. Rodent studies suggest that delta-9-tetrahydrocannabinol (THC) could increase addictive qualities of nicotine, but whether repeated THC exposure alters self-administration of nicotine has not been tested. We hypothesized that THC would increase the reinforcing effects of nicotine and alter nicotine intake. Adult...

Evaluation of the Modulatory Effects of Minor Cannabinoids and Terpenes on Delta-9-Tetrahydrocannabinol Discrimination in Rats.

Cannabis and Cannabinoid Research September 2023 Catherine F Moore, Julie A. Marusich, Mehdi Haghdoost et al.

Introduction: Cannabis contains a multitude of phytocannabinoids and terpenes in addition to its main psychoactive constituent, delta-9-tetrahydrocannabinol (D9-THC). It is believed that the combination of minor cannabinoids and terpenes with D9-THC may impact the subjective and physiological effects of D9-THC. In this study, select minor cannabinoids (cannabigerol [CBG], cannabidivarin [CBDV],...

Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists.

Neuropharmacology May 15, 2018 Julie A. Marusich, Jenny L Wiley, Timothy W Lefever et al.

Diversion of synthetic cannabinoids from the lab to drugs of abuse has become increasingly prevalent in recent years. Moreover, as earlier synthetic cannabinoids were banned, manufacturers introduced a new supply of novel compounds to serve as replacements. Hence, the chemical diversity of synthetic cannabinoid analogs has also rapidly increased. The present study examined 8 new synthetic...

DOI: 10.1016/j.neuropharm.2017.10.041 (opens in new tab) Full text (opens in new tab) Abuse liability Drug discrimination Receptor binding Synthetic cannabinoids +1

Comparison of the discriminative stimulus and response rate effects of Δ9-tetrahydrocannabinol and synthetic cannabinoids in female and male rats.

Drug and Alcohol Dependence March 1, 2017 Jenny L Wiley, Timothy W Lefever, Julie A. Marusich et al.

Women report greater sensitivity to the subjective effects of Δ9-tetrahydrocannabinol (THC). Similarly, female rodents tend to be more sensitive to some pharmacological effects of THC and synthetic cannabinoids. This study examined sex differences in discriminative stimulus and response rate effects of THC and synthetic cannabinoids in rats. A cumulative dosing THC discrimination procedure was...

Combination Chemistry: Structure-Activity Relationships of Novel Psychoactive Cannabinoids.

Current Topics in Behavioral Neurosciences 2017 Jenny L Wiley, Julie A. Marusich, Brian F Thomas

Originally developed as research tools for use in structure-activity relationship studies, synthetic cannabinoids contributed to significant scientific advances in the cannabinoid field. Unfortunately, a subset of these compounds was diverted for recreational use beginning in the early 2000s. As these compounds were banned, they were replaced with additional synthetic cannabinoids with...

Just add water: cannabinoid discrimination in a water T-maze with FAAH(-/-) and FAAH(+/+) mice.

Behavioural Pharmacology August 2016 Jenny L Wiley, Timothy W Lefever, Nikita S Pulley et al.

Incomplete overlap in the discriminative stimulus effects of Δ-tetrahydrocannabinol (THC) and the endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol has been reported in food-reinforced tasks. The aim of this study was to examine cannabinoid discriminative stimulus effects in a nonappetitive procedure. Adult male mice lacking the gene for AEA's major metabolic enzyme, fatty acid...

The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue.

Neuropharmacology February 2016 Julie A. Marusich, Kateland R Antonazzo, Bruce E. Blough et al.

In recent years, use of psychoactive synthetic stimulants has grown rapidly. 5-(2-Aminopropyl)indole (5-IT) is a synthetic drug associated with a number of fatalities, that appears to be one of the newest 3,4-methylenedioxymethamphetamine (MDMA) replacements. Here, the monoamine-releasing properties of 5-IT, its structural isomer 6-(2-aminopropyl)indole (6-IT), and MDMA were compared using in...

DOI: 10.1016/j.neuropharm.2015.09.004 (opens in new tab) Full text (opens in new tab) 3,4-Methylenedioxymethamphetamine MDMA 5-2-aminopropylindole 5-it 6-2-aminopropylindole 6-it Locomotor activity +2

Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines

Journal of Neuroscience November 12, 2014 Michael H. Baumann, Ernesto Solis, Lucas R. Watterson et al. 157 citations

The abuse of synthetic psychoactive substances known as "designer drugs," or "new psychoactive substances" (NPS), is increasing at an alarming rate. NPS are purchased as alternatives to traditional illicit drugs of abuse and are manufactured to circumvent laws regulating the sale and use of controlled substances. Synthetic cathinones (i.e., "bath salts") and synthetic cannabinoids (i.e.,...

DOI: 10.1523/jneurosci.3223-14.2014 (opens in new tab) Full text (opens in new tab) MDMA Synthetic cannabinoids Designer drug Recreational drug +4

Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats.

Pharmacology, Biochemistry, and Behavior September 2014 Jenny L Wiley, Timothy W Lefever, Ricardo A Cortes et al.

Synthetic indole-derived cannabinoids, originally developed to probe cannabinoid CB1 and CB2 receptors, have become widely abused for their marijuana-like intoxicating properties. The present study examined the effects of indole-derived cannabinoids in rats trained to discriminate Δ(9)-tetrahydrocannabinol (Δ(9)-THC) from vehicle. In addition, the effects of Δ(9)-THC in rats trained to...

DOI: 10.1016/j.pbb.2014.05.016 (opens in new tab) Full text (opens in new tab) Discriminative stimulus Jwh-018 Jwh-073 Jwh-210 +2

Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.

Neuropharmacology December 2013 Jenny L Wiley, Julie A. Marusich, Timothy W Lefever et al.

Synthetic indole-derived cannabinoids have become commonly used recreational drugs and continue to be abused despite their adverse consequences. As compounds that were identified early in the epidemic (e.g., naphthoylindoles) have become legally banned, new compounds have appeared on the drug market. Two tetramethylcyclopropyl ketone indoles, UR-144...

DOI: 10.1016/j.neuropharm.2013.07.022 (opens in new tab) Full text (opens in new tab) Abuse liability Delta-9-tetrahydrocannabinol Drug discrimination Synthetic cannabinoids +2

The Reinforcing and Rewarding Effects of Methylone, a Synthetic Cathinone Commonly Found in “Bath Salts”

Journal of Addiction Research & Therapy December 1, 2012 Lucas R. Watterson, L. Hood, Kaveish Sewalia et al. 71 citations

Methylone is a member of the designer drug class known as synthetic cathinones which have become increasingly popular drugs of abuse in recent years. Commonly referred to as “bath salts”, these amphetamine-like compounds are sold as “legal” alternatives to illicit drugs such as cocaine, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). Following their dramatic rise in...